Crystallographic report: Crystal structure of the first alkaline earth metal compound with the antibacterial drug sulfasalazine: [Sr(H-Sulf)(H2O)6](H-Sulf)·3H2O

Structural insight and in silico prediction of the pharmacokinetic parameters and toxicity of alkaline earth metal compounds strontium and barium with the non-steroidal anti-inflammatory drug nimesulide

In the crystals of alkaline earth metal compounds strontium and barium with the non-steroidal anti-inflammatory drug nimesulide, the strontium cation is nine-coordinated with a distorted tricapped trigonal prismatic geometry TCTPR-9, whereas the ten-coordinated barium ion exhibits a distorted tetracapped trigonal prismatic geometry TCTPR-10.

Spectroscopic, thermal and antitumor investigations of sulfasalazine drug in situ complexation with alkaline earth metal ions

The complexes of sulfasalazine (H(3)Suz) with some of alkaline metals Mg(II), Ca(II), Sr(II) and Ba(II) have been investigated. Sulfasalazine complexes were synthesized and characterized by spectroscopic tools; infrared spectra, electronic and mass spectra. The IR spectra of the prepared complexes were suggested that the H(3)Suz behaves as a bi-dentate ligand through the carboxylic and phenolic groups. The molar conductance measurements gave an idea about the non-electrolytic behavior of the H(3)Suz complexes. The thermal decomposition processes for metal(II) complexes of H(3)Suz viz: [M(HSuz)(H(2)O)(4)] (where M = Mg(II), Ca(II), Sr(II) or Ba(II)) have been accomplished on the basis of TG/DTG and DTA studies, and the formula conforms to the stoichiometry of the complexes based on elemental analysis. The kinetic analyses of the thermal decomposition were studied using the Coats-Redfern and Horowitz-Metzger equations. The antitumor and antimicrobial activities of the H(3)Suz and their alkaline metal(II) complexes were evaluated.

(Sulfasalazinato-κO)bis-(triphenyl-phosphine-κP)copper(I)

The title mixed-ligand copper(I) complex, [Cu(C₁₈H₁₃N₄O₅S)(C₁₈H₁₅P)₂], was synthesized via solvothermal reaction of [Cu(PPh₃)₂(MeCN)₂]ClO₄ and sulfasalazine [systematic name: 2-hydr­oxy-5-(2-{4-[(2-pyridylamino)sulfon­yl]phen­yl}diazen­yl)benzoic acid]. The mononuclear complex displays a trigonal coordination geometry for the Cu(I) atom, which is surrounded by two P-atom donors from two different PPh₃ ligands and one O-atom donor from the monodentate carboxyl­ate group of the sulfasalazinate ligand. The latter ligand is found in a zwitterionic form, with a deprotonated amine N atom and a protonated pyridine N atom. Such a feature was previously described for free sulfasalazine. The crystal structure is stabilized by C—H⋯O, C—H⋯N, N—H⋯N and O—H⋯O hydrogen bonds.